rosuvastatin calcium

This page shows the latest rosuvastatin calcium news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca settles with generic rivals in Crestor patent challenge

The company said it has entered into a settlement agreement with Actavis and Egis Pharmaceuticals over their plan to launch generic Crestor (rosuvastatin calcium), blocking competition for the product until May ... Actavis (formerly Watson Pharma) filed

Latest news

AstraZeneca wins stay on Crestor generics in US

The court upheld an earlier district court ruling that the 314 patent on the active substance in Crestor - rosuvastatin calcium - is valid and enforceable, preventing generic drugmakers from launching copycat versions ... All the generic drugmakers with
AstraZeneca’s Evan Lippman takes US role at Merck KGaA

Lippman joins EMD Serono from AstraZeneca (AZ) where he most recently served as executive director of the company's Crestor (rosuvastatin calcium) brand.
Crestor can't top Lipitor in head-to-head study

A study comparing the effects of AstraZeneca's Crestor (rosuvastatin calcium) with Pfizer's Lipitor (atorvastatin calcium) in has found no difference between the statin drugs in preventing the progression of ... The SATURN trial was designed to look at
AZ's Q3 income up as sales stay flat

The company said more than $350m of revenue was lost due to generic competition, cancelling out strong performances for statin Crestor (rosuvastatin calcium), antipsychotic Seroquel XR (quetiapine fumarate) and Symbicort
AstraZeneca partners with cooking website

rosuvastatin calcium), which is approved to lower cholesterol in combination with diet and exercise.

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest appointments

Evan Lippman joins Aileron Therapeutics

Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Experienced Editor, London, Medical Communications: Competitive package

Director Healthcare PR Communications: Salary TBC

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Account Director: Negotiable

Account Manager, Healthcare Advertising: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Director – Head of Public Affairs: Neg

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Scientific Team Lead: Competitive Salary

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Associate Medical Director: Highly Competitive

Senior Medical Writer (Remote Working): Competitive Salary Offered

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Scientific Director: Highly Competitive Salary &Benefits

Senior Account Executive – Medical Communications: Salary TBC

Associate Medical Director: Salary TBC

Account Director – Global Healthcare PR: Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Director - Digital: Great salary and benefits

Subscribe to our email news alerts

PMHub

Add my company

GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe’s leading hub for life sciences innovation...
Tackling a formidable foe: Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Cancer care – the power of new technologies: With patient numbers set to soar, how can we make a difference?...